1. Home
  2. HDSN vs OABI Comparison

HDSN vs OABI Comparison

Compare HDSN & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hudson Technologies Inc.

HDSN

Hudson Technologies Inc.

HOLD

Current Price

$6.11

Market Cap

239.9M

ML Signal

HOLD

Logo OmniAb Inc.

OABI

OmniAb Inc.

HOLD

Current Price

$1.37

Market Cap

237.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HDSN
OABI
Founded
1991
2012
Country
United States
United States
Employees
N/A
89
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
239.9M
237.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HDSN
OABI
Price
$6.11
$1.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$9.00
$4.50
AVG Volume (30 Days)
235.9K
547.8K
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.37
N/A
Revenue
$237,118,000.00
N/A
Revenue This Year
$2.51
$52.42
Revenue Next Year
$2.38
$64.69
P/E Ratio
$17.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.62
$1.22
52 Week High
$10.52
$2.22

Technical Indicators

Market Signals
Indicator
HDSN
OABI
Relative Strength Index (RSI) 45.21 34.32
Support Level $5.63 $1.32
Resistance Level $6.44 $1.70
Average True Range (ATR) 0.20 0.09
MACD 0.02 -0.01
Stochastic Oscillator 23.28 1.72

Price Performance

Historical Comparison
HDSN
OABI

About HDSN Hudson Technologies Inc.

Hudson Technologies Inc is an American industrial products manufacturer. It develops products which are mainly used in commercial air conditioning, industrial processing, and refrigeration systems. The company products include refrigerant and industrial gases, refrigerant management services and RefrigerantSide services, which consist of system decontamination. These are performed at customer's site using its Zugibeast system, which is a fast and portable system and allows the R-Side services team to accelerate critical services while saving customers time, money and aggravation. The company also owns a web-based real-time monitoring service which is used in the facility's refrigeration systems and other energy systems.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: